Table 1.
List of categories and indicators (14 in total) in the selected biomedical research areas (AD, BC, PC) financed through FP5, FP6, FP7 and H2020 ( between 1999 and 2020). As specified in the table, some indicators could not be analysed for the entire reference period/ EU-funded projects or all the selected biomedical areas.
| Category | Indicators |
|---|---|
| Funding and economic | 1. Number of projects |
| 2. Value of projects (Euros) | |
| 3. Value of co-financing (Euros) from other institutions of projects | |
| Dissemination | 4. Number of publications |
| 5. Number of citations of publications | |
| Scientific and technological | 6. Number of patents suitable to study the selected diseases and/or test new drugs- only data from FP7 and H2020 projects were considered |
| 7. Number of projects targeting diagnostic tools established | |
| 8. Number of projects targeting drugs, treatments or medical devices that have been developed/discovered | |
| 9. Number of projects targeting clinical trials for new drugs initiated | |
| 10. Number of projects targeting prevention measures | |
| Regulatory and policy measures | 11. Contributions of EU-funded research to regulatory and policy actions (e.g. public health guidance values/opinions; regulatory policy actions; non-regulatory targeted policy actions) |
| Main public health trends | 12. European indicator: Public health trends (i.e., deaths per 100 000 inhabitants and incidence per 100 000 inhabitants) between 2011 and 2019 |
| Education, training, and job opportunities | 13. Number of staff/researchers employed—only data from H2020 were considered |
| 14. New learning opportunities |